Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.
Bengaluru: Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.
"Nafamostat (has been) identified as a potential candidate for COVID-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany," the company said in a statement.
Click here to follow LIVE updates on coronavirus outbreak
Related Articles
The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.
Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.
also read
China under new COVID cloud, cases to peak at 65 million per week by June end
The latest wave is fueled by the newest XBB Omicron variant that has led to spike in cases starting late April. Reports say COVID-19 cases will reach nearly 40 million per week in May before peaking at 65 million a week by the end of May
Feline Felons: How a former British cop and partner made £280,000 by selling sick and dying cats to customers
Former British Transport Police officer Amy Byrne and partner, Harry Angell, have been sentenced to three years in jail for running a cat scam. They would buy sick kittens as cheap as £50 (Rs 5,150) and then sell them for £1,500 (Rs 1.5 lakh) – earning over £280,000 (Rs 2.8 crore) over the years
India’s tightrope geopolitical walk: Is this the new order?
On account of the bold and independent policies, both domestic and foreign, pursued by Prime Minister Narendra Modi’s government, India has been successful in dealing relatively effectively with the challenges posed by different circumstances